Zoek een klinische studie of trial
Andere zoekoptie(s)
23 Resultaat/Resultaten
Aanwerving proef
= 
; Lopend onderzoek
= 
; Gefinancierd door een IRDiRC-lid = 
; Lid van een ERN = 
Nationale klinische studie(s)
FRANKRIJK
HAUTS-DE-FRANCE
LILLE
OVIMA : Phase II Trial of Oral Vinorelbine in Children With Recurrent or Progressive Unresectable Low-Grade Glioma
CLCC Oscar Lambret
Unité d'oncologie pédiatrique
FRANKRIJK
ILE-DE-FRANCE
VILLEJUIF
VINILO: Phase I-II Study of Vinblastine in Combination With Nilotinib in Children, Adolescents, and Young Adults With Refractory or Recurrent Low-Grade Glioma - FR
CLCC Institut Gustave Roussy
Département de Cancérologie de l'enfant et de l'adolescent
OOSTENRIJK
WIEN
WIEN
VINILO: Phase I-II Study of Vinblastine in Combination With Nilotinib in Children, Adolescents, and Young Adults With Refractory or Recurrent Low-Grade Glioma - AT
Allgemeines Krankenhaus der Stadt Wien
Klinische Abteilung für Neonatologie, Pädiatrische Intensivmedizin und Neuropädiatrie
OOSTENRIJK
WIEN
WIEN
Phase I/II Open Label, Dose Escalation Trial to Determine the MTD, Safety, PK and Efficacy of Afatinib Monotherapy in Children Aged 1 Year to <18 Years With Recurrent/Refractory Neuroectodermal Tumours, Rhabdomyosarcoma and/or Other Solid Tumours With Known ErbB Pathway Deregulation Regardless of Tumour Histology - AT
St. Anna Kinderspital
Zentrum für Kinder- und Jugendheilkunde
POLEN
Warszawa
WARSAW
Cooperative Multicenter Study for Children and Adolescents With Low Grade Glioma - PL
Instytut "Pomnik-Centrum Zdrowia Dziecka"
Klinika Onkologii IP-CZD
PORTUGAL
NORTE
PORTO
Cooperative Multicenter Study for Children and Adolescents With Low Grade Glioma - PT
Centro Hospitalar Universitário de S. João, EPE
Unidade de Hematologia e Oncologia Pediátrica
USA
California
LA JOLLA
A Phase II Trial of Poly-ICLC in the Management of Recurrent Pediatric Low Grade Gliomas - US
University of California San Diego
University of California, San Diego
FRANKRIJK
AUVERGNE-RHONE-ALPES
GRENOBLE
Molecular and Cellular Print Medical Device Validation in Adult Glioma Tumors (Phase I) - FR
Centre Hospitalier Universitaire Grenoble Alpes
ITALIË
LAZIO
ROMA
Phase II Open-label Global Study to Evaluate the Effect of Dabrafenib in Combination With Trametinib in Children and Adolescent Patients With BRAF V600 Mutation Positive Low Grade Glioma (LGG) or Relapsed or Refractory High Grade Glioma (HGG) - IT
IRCCS Ospedale Pediatrico Bambino Gesù - SEDE GIANICOLO
U.O. di Oncoematologia
DUITSLAND
Berlin
ADDRESS: NOT PROVIDED - DE
PIVOT IO 020: Phase 1/2 Study of Bempegaldesleukin in Combination With Nivolumab in Children, Adolescents, and Young Adults With Recurrent or Refractory Malignancies - DE
Institution: Information not provided - DE
FRANKRIJK
HAUTS-DE-FRANCE
LILLE
Cilengitide (EMD121974) in combination with irradiation in children and young adults with newly diagnosed diffuse intrinsic pontine glioma : Phase I study
CLCC Oscar Lambret
Unité d'oncologie pédiatrique
FRANKRIJK
ILE-DE-FRANCE
PARIS
A Study Evaluating Dexamfetamine Sulphate in Patients With Glioma Suffering From Severe Asthenia. A Phase III Double-blind Randomized Placebo-controlled Trial
AP-HP.Sorbonne Université - Hôpital de la Pitié-Salpêtrière
Unité Fonctionnelle Epilepsie
FRANKRIJK
ILE-DE-FRANCE
VILLEJUIF
BIOMEDE: Biological Medicine for Diffuse Intrinsic Pontine Glioma (DIPG) Eradication (Phase II) - FR
CLCC Institut Gustave Roussy
Département de Cancérologie de l'enfant et de l'adolescent
OOSTENRIJK
NIEDERÖSTERREICH
ST. PÖLTEN
LAHENE Study: Perioperative Levetiracetam for seizure prophylaxis in brain tumor patients. Prospective evaluation of side effects and efficacy (phase 2)
Universitätsklinikum St. Pölten
Karl Landsteiner Institut für klinische Neurologie und Neuropsychologie
OOSTENRIJK
WIEN
WIEN
A Phase II, Open-label, Study in Subjects With BRAF V600E-Mutated Rare Cancers With Several Histologies to Investigate the Clinical Efficacy and Safety of the Combination Therapy of Dabrafenib and Trametinib - AT
Allgemeines Krankenhaus der Stadt Wien
Klinische Abteilung für Onkologie
SPANJE
Madrid
ADDRESS: NOT PROVIDED - ES
Phase II open-label global study to evaluate the effect of dabrafenib in combination with trametinib in children and adolescent patients with BRAF V600 mutation positive relapsed or refractory High Grade Glioma (HGG) - ES
Institution: Information not provided - ES
SPANJE
Madrid
ADDRESS: NOT PROVIDED - ES
Phase 1/2 Study of Bempegaldesleukin in Combination With Nivolumab in Children, Adolescents, and Young Adults With Recurrent or Refractory Malignancies (PIVOT IO 020) - ES
Institution: Information not provided - ES
ZWITSERLAND
Suisse Alémanique
BERN
LSCI-NSURG: Intraoperative Laser Speckle Contrast Imaging to Assess Blood Flow During Neurosurgery
Universitätsspital Inselspital
Universitätsklinik für Neurochirurgie
NEDERLAND
Noord-Holland
AMSTERDAM
The Drug Rediscovery Protocol (DRUP trial): A Dutch National Study on behalf of the Center for Personalized Cancer Treatment (CPCT) to Facilitate Patient Access to Commercially Available, Targeted Anti-cancer Drugs to determine the Potential Efficacy in Treatment of Advanced Cancers with a Known Molecular Profile (Phase II)
Het Nederlands Kanker Instituut - Antoni van Leeuwenhoek Ziekenhuis
Afdeling Maag-Darm-Leveroncologie
BELGIË
ARRONDISSEMENT BRUSSELS-CAPITAL
BRUSSELS
STEP: Sorafenib Long Term Extension Program - BE
Cliniques universitaires Saint-Luc - UCLouvain
Pneumologie_Oncologie thoracique
ITALIË
LAZIO
ROMA
An Open-Label, Single-Arm, Phase 1/2 Study Evaluating the Safety and Efficacy of Ponatinib for the Treatment of Recurrent or Refractory Leukemias or Solid Tumors in Pediatric Participants - IT
IRCCS Ospedale Pediatrico Bambino Gesù - SEDE GIANICOLO
U.O. di Oncoematologia
Multinationale klinische studie(s)
FRANKRIJK
AUVERGNE-RHONE-ALPES
ADDRESS: NOT PROVIDED - FR
VINILO: Phase I-II Study of Vinblastine in Combination With Nilotinib in Children, Adolescents, and Young Adults With Refractory or Recurrent Low-Grade Glioma
Institution: Information not provided - FR
VERENIGD KONINKRIJK
Leicestershire
LEICESTER